4World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
5Kitabchi AE, Umpierrez GE, Murphy MB, et al. American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care. 2004, 27 Suppl 1:S94-102.
6Siraj ES, Reddy SS, Scherbaum WA, et al. Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Diabetes Care, 2002, 25:453-457.
7Palmer JP, Fleming GA, Greenbanm CJ, et al. C-poptide is the appropriate outcome measure, for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes, 2004, 53:250-264.
8Atkinsen MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 2001, 358: 221-229.
9Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev, 2002, 18:192-200.
10Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet, 2004,364 : 1699-1700.
